Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-17

Clinical Trial Update: Pre-Exposure Prophylaxis for Transgender Women in the US and South America [Phase 2, Phase 3]

View source ↗

Summary

HIV Prevention Trials Network completed Phase 2/Phase 3 clinical trials evaluating pre-exposure prophylaxis for transgender women in the United States and South…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: HIV Prevention Trials Network | Conditions: HIV Prevention | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2025-12-17